Recombinant CD19 Glycomutant Accurately and Reproducibly Detects CD19-Directed CAR-T Cells By Flow Cytometry

被引：1
|
作者：
Kirchmeier, Delaney R. [1 ]
Sheih, Alyssa [2 ,3 ]
Fiorenza, Salvatore [3 ]
Hirayama, Alexandre V. [3 ]
Chou, Cassie [3 ,4 ]
Kimble, Erik [3 ,5 ]
Gauthier, Jordan [3 ]
Williams, Alison [3 ]
Price, Jason [3 ]
Correnti, Colin [3 ,6 ]
Turtle, Cameron J. [3 ,5 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
[2] Umoja Biopharma, Seattle, WA USA
[3] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA
[4] Genentech Inc, San Francisco, CA 94080 USA
[5] Univ Washington, Dept Med, Seattle, WA USA
[6] Link Immunotherapeut, Seattle, WA USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-148229
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1724
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Beyond CD19 CAR-T cells in lymphoma
    Leung, Wingchi K.
    Ayanambakkam, Adanma
    Heslop, Helen E.
    Hill, LaQuisa C.
    CURRENT OPINION IN IMMUNOLOGY, 2022, 74 : 46 - 52
  • [2] CD19-directed CAR T cells gain traction
    Schuster, Stephen J.
    LANCET ONCOLOGY, 2019, 20 (01): : 2 - 3
  • [3] OPTIMIZATION OF CAR-T CD19 MONITORING BY FLOW CYTOMETRY AND QUANTITATIVE PCR (Q PCR)
    Garcia-Ortiz, A.
    Rapado, I
    Encinas, J.
    Maroto-Martin, E.
    Sanchez-Pina, J. M.
    Garrido, V
    Moreno Sanz, L.
    Juarez Rufian, A.
    Rufian Vazquez, L.
    Caceres Garcia, M.
    Paciello, M.
    Alonso, R.
    Cedena, T.
    Valeri, A.
    Martinez Lopez, J.
    HAEMATOLOGICA, 2019, 104 : 164 - 164
  • [4] CD19 COMPLETE OR PARTIAL LOSS IS A MAJOR MECHANISM OF RELAPSE IN DLBCL PATIENTS TREATED WITH CD19-DIRECTED CAR-T CELLS: EXPERIENCE OF PERUGIA HEMATOLOGY CENTER
    Perriello, V. M.
    Falini, L.
    Ruggeri, L.
    Venanzi, A.
    Zei, T.
    Iacucci-Ostini, R.
    Pierini, A.
    Ballanti, S.
    Tiacci, E.
    Falini, B.
    HAEMATOLOGICA, 2022, 107 : 93 - 93
  • [5] CD19 CAR T Cells
    Sadelain, Michael
    CELL, 2017, 171 (07) : 1471 - 1471
  • [6] Toxicities of CD19 CAR-T cell immunotherapy
    Hirayama, Alexandre V.
    Turtle, Cameron J.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 : S42 - S49
  • [7] Challenge of cryopreservation for gmp grade CD19 CAR-T cells
    Gong, Wenjie
    Wang, Lei
    Wang, Sanmei
    Neuber, Brigitte
    Sellner, Leopold
    Schubert, Maria-Luisa
    Hueckelhoven-Krauss, Angela
    Kunz, Alexander
    Gern, Ulrike
    Michels, Birgit
    Hinkelbein, Mandy
    Mechler, Stefanie
    Richter, Petra
    Mueller-Tidow, Carsten
    Dreger, Peter
    Schmitt, Michael
    Schmitt, Anita
    BONE MARROW TRANSPLANTATION, 2019, 54 : 186 - 187
  • [8] CD19-Directed CAR T-Cells in a Patient With Refractory MOGAD
    Cabrera-Maqueda, Jose Maria
    Sepulveda, Maria
    Garcia, Raquel Ruiz
    Munoz-Sanchez, Guillermo
    Martinez-Cibrian, Nuria
    Ortiz-Maldonado, Valentin
    Lorca-Arce, Daniel
    Guasp, Mar
    Llufriu, Sara
    Martinez-Hernandez, Eugenia
    Armangue, Thais
    Fonseca, Elianet G.
    Alba-Isasi, Maria Teresa
    Delgado, Julio
    Dalmau, Josep
    Juan, Manel
    Saiz, Albert
    Blanco, Yolanda
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2024, 11 (05):
  • [9] Evolution and Proliferation of CD7 CAR-T Cells Compared to CD19 CAR-T Cells Therapies for Acute Leukemia
    Zhang, Xian
    Zhang, Gailing
    Li, Wenqian
    Qiu, Liyuan
    Wang, Dongchu
    Yang, Junfang
    Li, Jingjing
    Lu, Peihua
    BLOOD, 2021, 138
  • [10] Safety and efficacy of co-administration of CD19 and CD22 CAR-T cells in children with B-ALL relapse after CD19 CAR-T therapy
    Wenjie Li
    Lixia Ding
    Wenhua Shi
    Xinyu Wan
    Xiaomin Yang
    Jing Yang
    Tianyi Wang
    Lili Song
    Xiang Wang
    Yani Ma
    Chengjuan Luo
    Jingyan Tang
    Longjun Gu
    Jing Chen
    Jun Lu
    Yanjing Tang
    Benshang Li
    Journal of Translational Medicine, 21
12345